Healthcare >> Analyst Interviews >> August 6, 2001
LOUIS C. WEBB, JR., is a Principal with Dain Rauscher Wessels, focusing
on drug delivery and specialty pharmaceuticals as part of the Life
Sciences equity research team. He has 25 years' experience following the
pharmaceutical sector, including four years as Vice President, research
at Fahnestock & Co. and six years as First Vice President, research at
Robert W. Baird & Co. Mr. Webb received a Bachelor of Science degree in
Engineering and Applied Science from Yale University in 1975 and became
a Chartered Financial Analyst in 1980. He is a member of AIMR and the
NYSSA. In The Wall Street Journal annual analyst survey, Mr. Webb ranked
first in pharmaceutical stock picking in 2000 and first in
pharmaceutical earnings estimate accuracy in 1996. Mr. Webb lives in
Ossining, New York, and includes sailing among his personal interests. Profile
TWST: Louis, what do investors need to understand about drug deliverystocks? Where do they fit in the pharmaceutical arena?
Mr. Webb: We view the drug delivery sector as offering